NasdaqGM:HROWPharmaceuticals
Is It Time To Revisit Harrow (HROW) After Its Strong Multi Year Share Price Run?
If you are wondering whether Harrow's share price still makes sense after recent moves, you are not alone and the numbers give us plenty to talk about.
The stock trades at US$48.49, with a 7 day return of a 5% decline, a 30 day return of 8.3% and a 1 year return of 44.9%, while the 3 year return is very large and the 5 year return is also very large.
Recent news flow around Harrow has mainly focused on its position in the pharmaceuticals and biotech space and investor interest in how its...